top of page


Global drug development, clinical development and regulatory strategy. His consulting practice, Chaikin Associates LLC, focuses upon:
  • International drug development/regulatory strategies for new chemical entities and biologics across multiple therapeutic areas
  • Preparation of drug development plans to secure regulatory approvals in major markets, such as the United States, European Union and  Japan
  • The development of exploratory drug development strategies incorporating appropriate biomarkers for proof of concept studies to enhance asset valuation
  • Representation of biotechnology and pharmaceutical companies at regulatory agency meetings in the United States and Europe
  • Performance of Due Diligence activities for individual drug assets or product portfolios
  • Preparation of company executives for FDA advisory committee meetings.
  • Advising the investment community on the scientific merit of drug
    product assets

  • Dr. Chaikin spent over 30 years in Pharma R&D and was most recently Executive Vice President for Drug Development at Kyowa Pharmaceuticals and the Head of International Drug Development for Kyowa Hakko Kogyo
  • During his career in industry, Dr. Chaikin played a pivotal role in the development, registration and successful commercialization of many compounds including: Lovenox, Taxotere, Campto, Azmacort HFA, Intal HFA, Nasocort AQ, Procardia XL, Glucotrol XL, Myocet, Amaryl, Altace, Ebastine, Synercid and Serzone
  • A Fellow of the American College of Clinical Pharmacology
  • Author of over 70 manuscripts and abstracts
  • He is the 2013 recipient of the American College of Clinical Pharmacology Nathaniel Kwitt Distinguished Service Award
  • He is an Adjunct Professor in the Department of Pharmaceutics at the University of Florida College of Pharmacy
  • Adjunct Professor in the Department of Pharmacy Practice and Administration at Rutgers University School of Pharmacy
Positions Held
  • Vice President of Oncology Research and Development at Elan Pharmaceuticals
  • Vice President of Worldwide Clinical Development at Rhone-Poulenc Rorer/Aventis Pharmaceuticals
  • Vice President of Clinical Development at Hoechst-Roussel Pharmaceuticals
  • Director of Clinical Pharmacology at Bristol Myers Squibb
  • Senior Associate Medical Director and Global Project Leader for Pfizer Pharmaceuticals
  • Senior Research Scientist, Drug Metabolism and Pharmacokinetics, Ortho Pharmaceutical Corporation
  • Doctor of Pharmacy Degree from the University of Maryland School of Pharmacy
  • Completed a Fellowship in Clinical Pharmacology at the University of Maryland Hospital in Baltimore, Maryland
  • Holds a M.D. degree from Rutgers University-New Jersey Medical School.
  • He performed his internal medicine training at Robert Wood Johnson University Hospital in New Brunswick, NJ.
bottom of page